Literature DB >> 714592

Hypertension associated with the Guillain-Barré syndrome.

F B Stapleton, R R Skoglund, R B Daggett.   

Abstract

Guillain-Barré syndrome (GBS) is frequently complicated by hypertension, which has been ascribed to sympathetic nervous system hyperactivity. We report the case of a child with GBS and hypertension that appeared to be related to increased renin-angiotensin activity. Urinary catecholamine excretion was normal. Propranolol therapy successfully controlled the hypertension. Evaluation of the renin-angiotensin system and catecholamine excretion is indicated in patients with GBS and hypertension.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 714592

Source DB:  PubMed          Journal:  Pediatrics        ISSN： 0031-4005            Impact factor:   7.124


  5 in total

1.  Raised plasma renin activity in the hypertension of the Guillain-Barré syndrome.

Authors:  J Laufer; J Passwell; G Keren; N Brandt; B E Cohen
Journal:  Br Med J (Clin Res Ed)       Date:  1981-04-18

2.  Severe hypertension: an unusual presentation of Guillain-Barré syndrome in a child with brucellosis.

Authors:  Y A Al-Eissa; A S Al-Herbish
Journal:  Eur J Pediatr       Date:  1996-01       Impact factor: 3.183

3.  Dysaesthesias and dysautonomia: a self-limited syndrome of painful dysaesthesias and autonomic dysfunction in childhood.

Authors:  R Nass; A Chutorian
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-02       Impact factor: 10.154

4.  Severe hypertension and raised haematocrit: unusual presentation of Guillain-Barré syndrome.

Authors:  A M Richards; M G Nicholls; M E Beard; P J Parkin; E A Espiner
Journal:  Postgrad Med J       Date:  1985-01       Impact factor: 2.401

5.  Case Report: Intracranial Hypertension Secondary to Guillain-Barre Syndrome.

Authors:  Christina Doxaki; Eleftheria Papadopoulou; Iliana Maniadaki; Nikolaos G Tsakalis; Konstantinos Palikaras; Pelagia Vorgia
Journal:  Front Pediatr       Date:  2021-01-20       Impact factor: 3.418
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.